Mahamaya Lifesciences: CFO Resigns, MD Redesignated, New CFO Appointed
Mahamaya Lifesciences Ltd announced significant management changes following a Board of Directors meeting on August 25, 2026. Mr. Prashant Krishnamurthy will relinquish his role as Chief Financial Officer (CFO) on October 31, 2026, and will be redesignated as Managing Director effective November 1, 2026, subject to shareholder approval. Concurrently, Mr. Amarendra Mohapatra has been appointed as the new CFO and Key Managerial Personnel (KMP) from November 1, 2026. The company also approved the notice for its 24th Annual General Meeting (AGM) to be held on September 29, 2026, and appointed auditors for the financial year 2026-27. Several director appointments and re-appointments were also approved.
Key Highlights
- Mr. Prashant Krishnamurthy resigns as CFO, redesignated as MD.
- Mr. Amarendra Mohapatra appointed as new CFO.
- 24th AGM scheduled for September 29, 2026.
- New auditors appointed for FY 2026-27.
- Director appointments and re-appointments approved.
Price Impact
More from MAHALIFE